These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35201933)

  • 41. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    Huber CM; Yee C; May T; Dhanala A; Mitchell CS
    J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-Dependent Decline in Synaptic Mitochondrial Function Is Exacerbated in Vulnerable Brain Regions of Female 3xTg-AD Mice.
    Espino de la Fuente-Muñoz C; Rosas-Lemus M; Moreno-Castilla P; Bermúdez-Rattoni F; Uribe-Carvajal S; Arias C
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    Joseph DJ; Liu C; Peng J; Liang G; Wei H
    PLoS One; 2019; 14(10):e0223509. PubMed ID: 31600350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.
    Song JM; DiBattista AM; Sung YM; Ahn JM; Turner RS; Yang J; Pak DT; Lee HK; Hoe HS
    Exp Neurol; 2014 Feb; 252():105-13. PubMed ID: 24316432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
    Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Dietary Supplementation with Selenium-Enriched Yeast Improves Cognitive Impairment, Reverses Synaptic Deficits, and Mitigates Tau Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Zhang ZH; Wen L; Wu QY; Chen C; Zheng R; Liu Q; Ni JZ; Song GL
    J Agric Food Chem; 2017 Jun; 65(24):4970-4979. PubMed ID: 28578584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.
    Scuderi C; Bronzuoli MR; Facchinetti R; Pace L; Ferraro L; Broad KD; Serviddio G; Bellanti F; Palombelli G; Carpinelli G; Canese R; Gaetani S; Steardo L; Steardo L; Cassano T
    Transl Psychiatry; 2018 Jan; 8(1):32. PubMed ID: 29382825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
    Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
    Cells; 2021 May; 10(5):. PubMed ID: 34064687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice.
    Daini E; Vandini E; Bodria M; Liao W; Baraldi C; Secco V; Ottani A; Zoli M; Giuliani D; Vilella A
    Front Immunol; 2022; 13():1082036. PubMed ID: 36703981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
    Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
    J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ganglioside GQ1b ameliorates cognitive impairments in an Alzheimer's disease mouse model, and causes reduction of amyloid precursor protein.
    Shin MK; Choi MS; Chae HJ; Kim JW; Kim HG; Kim KL
    Sci Rep; 2019 Jun; 9(1):8512. PubMed ID: 31186474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
    Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
    Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of exercise on early sensorimotor performance alterations in the 3xTg-AD model of Alzheimer's disease.
    Bareiss SK; Johnston T; Lu Q; Tran TD
    Neurosci Res; 2022 May; 178():60-68. PubMed ID: 35033583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.